Friday, June 5, 2026

How Hanmi’s Dual Inhibitor HM97662 is Revolutionizing Cancer Treatment: Key Insights from AACR 2026

Hanmi Pharmaceutical to present nine groundbreaking cancer research studies at AACR 2026, showcasing innovative therapies and AI-driven analytics.

North Korea Issues First-Ever Wildfire Warning Following South Korea’s Devastating Blaze

North Korea issues its first wildfire risk advisory due to strong winds and low precipitation, responding to recent wildfires in South Korea.

China Is Buying Tons of North Korean Tungsten—And It’s Not Banned

North Korean tungsten is crucial in trade with China, raising concerns over sanctions due to its use in military applications.

Tag: bipolar disorder

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Bukwang Pharma Wins Phase 3 Approval to Expand Latuda Into Adjunctive Treatment for Major Depression

Bukwang Pharmaceutical received approval for a Phase 3 clinical trial of Lurasidone as an adjunctive treatment for MDD.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.